US Food and Drug Administration revised EUA for sotrovimab due to Omicron BA.2 subvariant
On Mar. 25, 2022, GlaxoSmithKline and Vir Biotechnology announced that the US Food and Drug Administration had amended…
On Mar. 25, 2022, GlaxoSmithKline and Vir Biotechnology announced that the US Food and Drug Administration had amended…
On Mar. 25, 2022, Icosavax announced the first subjects had been dosed with IVX-411, a virus-like particle (VLP)…
On Mar. 25, 2022, the WHO and the Government of India signed an agreement to establish the WHO…
On Mar. 23, 2022, Quest Diagnostics announced that it had been granted a contract by the Centers for…
On Mar. 22, 2022, Windtree Therapeutics announced results from its Phase 2 study of lucinactant (KL4 surfactant) for…
On Mar. 21, 2022, in support of the Cancer Moonshot? goal of fostering data sharing in cancer research,…
On Mar. 21, 2022, Twist Bioscience announced the launch of specific synthetic RNA positive controls for SARS-CoV-2 encapsulated…
On Mar. 17, 2022, Eiger BioPharmaceuticals announced that Peginterferon Lambda (Lambda) significantly reduced the risk of COVID-19-related hospitalizations…
On Mar. 17, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
On Mar. 16, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
On Mar. 16, 2022, Roche announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate…
On Mar. 14, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
On Mar. 11, 2022, the BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDCï¾’s Advisory Committee on Immunization…
On Mar. 10, 2022, Oragenics announced that it had entered into an agreement with KBI Biopharma for the…
On Mar. 10, 2022, Schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
On Mar. 10, 2022, Howard Hughes Medical Institute announced that after more than two decades of effort researchers…
On Mar. 9, 2022, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) announced a clinical…
On Mar. 9, 2022, Harvard Medical School announced that an international research team had completed an atlas of…
On Mar. 4, 2022, Oxitec announced the publication by the U.S. Environmental Protection Agency of its approval to…
On Mar. 7, 2022, the U.S. Food and Drug Administration announced it had made a low-risk determination for…
On Mar. 7, 2022, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
On Mar. 7, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
On Mar. 6, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
On Mar. 4, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
On Mar. 4, 2022, the WHO announced it had published an updated position paper on the RTS,S/AS01 (RTS,S)…
On Mar. 4, 2022, the CDC reported that COVID-19 vaccination coverage with the first dose of the primary…
On Mar. 3, 2022, the WHO and the Medicines Patent Pool (MPP) jointly welcomed the announcement that the…
On Mar. 3, 2022, a study carried out in southwestern Ontario identified a highly mutated variant of SARS-CoV-2…
On Mar. 2, 2022, Roche announced an initial donation of essential medicines to Ukraine. Roche is working diligently…
On Mar. 1, 2022, the CDC reported that Two doses of Pfizer-BioNTech vaccine protect against COVID-19ï¾–associated emergency department…